Robuta

https://health.economictimes.indiatimes.com/news/industry/we-want-to-set-global-benchmarks-for-affordable-cell-therapy-jogin-b-desai-founder-ceo-eyestem-research/81081940 We want to set global benchmarks for affordable cell therapy: Jogin B Desai, Founder & CEO, Eyestem... It is estimated that 170 million people suffer from dry age-related macular degeneration, out of which 15 to 40 million people are in India. This disease...